Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on market

  • 📰 CNBC
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 72%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.

asked the U.S. District Court for Maryland to preemptively block the FDA from pulling the company's 2019 approval to distribute the company's version of mifepristone.

GenBioPro has said in court filings that it supplies two-thirds of the mifepristone used in the U.S. for abortions. The lawsuit was lodged in response to a ruling last week by the U.S. 5th Circuit Court of Appeal, which upheld part of a sweeping order by Texas U.S. District Judge Matthew Kacsmaryk that blocks GenBioPro's generic approval by the FDA.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP

日本 最新ニュース, 日本 見出し